Skip to content

End-of-life distress: all studies

Page 30 of 40: studies 291 to 300 of 391, newest first. Back to the end-of-life distress overview

Research

The Role of Perennialist Thought in the Development of Psychedelic Research in the United States

May 4, 2022 Nathan Keele Springer

From the 1960s to the present day, American research into the therapeutic effects of psychedelic drugs has focused on their ability to facilitate “mystical” experiences in test subjects. “Mysticomimetic” research has close ties to perennialist notions of religion that gained popularity over the course of the 20th century. Figures such as William James and Aldous Huxley promoted perennialist...

DOI: 10.57709/30514807 (opens in new tab) Full text (opens in new tab) Psychedelic treatment Hallucinogenic therapy Entheogenic therapy Mind-altering drug therapy +19

Psychedelic-assisted psychotherapy for existential suffering: Facilitating self-transcendence at the end of life.

International Journal of Transpersonal Studies March 18, 2022 K. O. St. Arnaud

Although existential suffering is amongst the most devastating forms of distress experienced by many patients nearing the end-of-life, it is often unsatisfactorily addressed due to a paucity of effective interventions. However, both historic and recent studies of psychedelic-assisted psychotherapy have reported marked alleviation of this suffering. As such, this article seeks to advance the...

Ethics Committees Reimagined

Psychiatric News January 28, 2022 Claire Zilber

Back to table of contents Previous article Next article Ethics CornerFull AccessEthics Committees ReimaginedClaire Zilber, M.D.Claire Zilber, M.D.Published Online:28 Jan 2022https://doi.org/10.1176/appi.pn.2022.2.25The APA and district branch (DB) ethics committees used to stay busy processing complaints from patients, their family members, and colleagues about members who allegedly engaged in...

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

Frontiers in Psychiatry January 12, 2022 Shannon Dames, Pamela Kryskow, Crosbie Watler 38 citations

Amid an international pandemic and a worsening mental health crisis, ketamine-assisted therapy is emerging as a promising solution for those deemed “treatment resistant.” Post-traumatic stress disorder (PTSD) and depression are on the rise, with accelerating direct (e.g., burden of suffering) and indirect (e.g., disability/role impairment and impact on family) costs. Psychedelic-assisted...

Mindfulness-Based Acceptance and Commitment Therapy

Advances in Psychology, Mental Health, and Behavioral Studies 2022 Sindhu B. S.

Acceptance and Commitment Therapy (ACT) is one of the latest mindfulness-based behavior therapies shown to have compelling evidence and efficacy with a wide range of clinical conditions. ACT is so hard to categorize that it is often described as an amalgamation of existential, humanistic, cognitive-behavioural therapy. ACT is often referred as process-based CBT and is one of the ‘third-wave' of...

Why was early therapeutic research on psychedelic drugs abandoned?

Psychological Medicine 2022 Wayne Hall

Advocates of the therapeutic use of psychedelic drugs have argued that a promising approach to treatment was prematurely abandoned in the 1960s primarily because of Richard Nixon's 'War on Drugs'.This paper (1) briefly describes research in the 1950s and 1960s in North America on the use of LSD to treat alcohol dependence, anxiety in terminal illness, and anxiety and depression; and (2)...

Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer

Drug Science, Policy and Law 2022 Rayyan Zafar, Dustin Sulak, Jaime Brambila et al. 3 citations

A 49-year-old woman was diagnosed with an ER + , PR-, HER2 + , BRCA- invasive ductal carcinoma which progressed metastatically to include bone, liver, and lymph node involvement. Standardised care included a 26-month treatment period with targeted chemotherapy and a ketogenic diet. The patient also began a course of cannabinoid-based therapy, consisting initially of a titrated high-dose...

Psychosocial and Spiritual Aspects of Care

Palliative Care Perspectives December 1, 2021 James L. Hallenbeck

This chapter discusses the spiritual and psychosocial aspects of care using a narrative approach. It suggests that far more suffering in patients with advanced illness results from psychic rather than from physical distress, assuming physical symptoms are reasonably palliated. Categories of psychic distress described include depression, anxiety, and delirium. A discussion of anticipatory and...

Carl Jung and the Psychedelic Brain

International Journal of Jungian Studies September 9, 2021 Gary M. Clark

Abstract In this essay, I outline an approach to analytical psychology based on the emerging disciplines of psychedelic neuroscience and psychedelic assisted therapies. During the 1950s Jung made brief comments on the use of psychedelics in traditional cultures and therapeutic contexts. I analyse these comments in the light of consequent research in the field. Contemporary psychedelic...

Possível uso da Psilocibina no tratamento psiquiátrico, incluindo sequelas da COVID-19

Research, Society and Development August 22, 2021 Myla Christie Araújo Custódio Bonifácio, Pietra Bruna Batrbosa Bento, Kaynara Trevisan et al. 1 citation

Este trabalho discute acerca da ação da psilocibina no organismo humano e seu potencial terapêutico enquanto tratamento principal ou adjuvante para certos distúrbios psiquiátricos, mais especificamente a depressão e a ansiedade, como aquelas encontradas em pacientes que estão em cuidados paliativos e enfrentando o processo de fim de vida, mas também em pacientes nos quais o tratamento...